Compare Invesco DB Oil Fund (DBO) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Oil Fund vs DexCom, Inc. — how do they compare? Invesco DB Oil Fund trades at $20.98, while DexCom, Inc. trades at $90.64 (market cap $33.79B). The key difference: DexCom, Inc. is trading nearer its 52-week high, Invesco DB Oil Fund nearer its low. Which is the better fit depends on your goals.
| DBO | DXCM | |
|---|---|---|
Sector | Commodities - Energy | Health |
52-Week High | $23.80 | $89.53 |
52-Week Low | $11.98 | $54.84 |
Market Cap | — | $33.79B |
Enterprise Value | — | $33.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBO trades at $20.99, up 0.67% today, with a bullish technical signal from moving averages. The stock shows neutral oscillators but faces uniform support and resistance at $21. Recent news highlights oil market volatility due to Middle East tensions and OPEC demand forecast cuts, influencing energy sector sentiment.
The outlook is clouded by supply disruptions and demand uncertainty, posing risks for energy stocks. Investment appeal hinges on oil price stability and company-specific fundamentals, which require verification from recent SEC filings and earnings reports for a complete assessment.
DXCM trades at $91.00, up 3.82% today and near its 52-week high, with bullish technical signals from moving averages and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $0.70 versus $0.61 expected, driven by 13% revenue growth and margin expansion. The company raised full-year 2026 guidance, reflecting robust demand for continuous glucose monitors.
The outlook is positive due to sustained revenue growth, profitability improvements, and analyst consensus favoring buys. Risks include competitive pressures and potential regulatory scrutiny, but institutional ownership trends and earnings momentum support a constructive view for investors seeking exposure to medical technology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Invesco DB Oil Fund
DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
